Search Results for: APP

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
OXSR1 oxidative stress responsive kinase 1
  • Fostamatinib
P2RX6 purinergic receptor P2X 6
  • Elevation of cytosolic Ca2+ levels
  • Platelet homeostasis
  • Promethazine
P2RY2 purinergic receptor P2Y2
  • G alpha (q) signalling events
  • P2Y receptors
  • Surfactant metabolism
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • Promethazine
  • Suramin
  • Denufosol
  • INS 316
PABIR1 PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1
PABPC3 poly(A) binding protein cytoplasmic 3
PACRG parkin coregulated
PADI4 peptidyl arginine deiminase 4
  • Chromatin modifying enzymes
  • Citrulline
  • Azithromycin
  • Tetracycline
  • Streptomycin
  • N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide
  • Chlortetracycline
PAEP progestagen associated endometrial protein
  • 12-Bromododecanoic Acid
  • Palmitic Acid
  • Glycerin
PAGR1 PAXIP1 associated glutamate rich protein 1
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Formation of WDR5-containing histone-modifying complexes
  • Epigenetic regulation of gene expression by MLL3 and MLL4 complexes
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
PAIP2 poly(A) binding protein interacting protein 2
PAK1 p21 (RAC1) activated kinase 1
  • Generation of second messenger molecules
  • Regulation of actin dynamics for phagocytic cup formation
  • FCERI mediated MAPK activation
  • FCERI mediated MAPK activation
  • CD28 dependent Vav1 pathway
  • EPHB-mediated forward signaling
  • Ephrin signaling
  • Sema3A PAK dependent Axon repulsion
  • Activation of RAC1
  • Signal transduction by L1
  • Smooth Muscle Contraction
  • VEGFR2 mediated vascular permeability
  • CD209 (DC-SIGN) signaling
  • RHO GTPases activate PKNs
  • RHO GTPases Activate ROCKs
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • MAPK6/MAPK4 signaling
  • G beta:gamma signalling through CDC42
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOQ GTPase cycle
  • RHOH GTPase cycle
  • RHOJ GTPase cycle
  • RHOU GTPase cycle
  • RAC3 GTPase cycle
  • RHOV GTPase cycle
  • Fostamatinib
PAK2 p21 (RAC1) activated kinase 2
  • Nef and signal transduction
  • Generation of second messenger molecules
  • Regulation of PAK-2p34 activity by PS-GAP/RHG10
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • Stimulation of the cell death response by PAK-2p34
  • FCERI mediated MAPK activation
  • FCERI mediated MAPK activation
  • CD28 dependent Vav1 pathway
  • Ephrin signaling
  • Sema3A PAK dependent Axon repulsion
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • Smooth Muscle Contraction
  • VEGFR2 mediated vascular permeability
  • CD209 (DC-SIGN) signaling
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • MAPK6/MAPK4 signaling
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOQ GTPase cycle
  • RHOH GTPase cycle
  • RHOG GTPase cycle
  • RHOJ GTPase cycle
  • RHOU GTPase cycle
  • RAC3 GTPase cycle
  • RHOV GTPase cycle
  • Fostamatinib
PAK4 p21 (RAC1) activated kinase 4
  • Activation of RAC1
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOQ GTPase cycle
  • RHOH GTPase cycle
  • RHOG GTPase cycle
  • RHOJ GTPase cycle
  • RHOU GTPase cycle
  • RAC3 GTPase cycle
  • RHOV GTPase cycle
  • Fostamatinib
PAK6 p21 (RAC1) activated kinase 6
  • Activation of RAC1
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RHOD GTPase cycle
  • RHOH GTPase cycle
  • RHOV GTPase cycle
  • Fostamatinib
PAPSS2 3'-phosphoadenosine 5'-phosphosulfate synthase 2
  • Transport and metabolism of PAPS
  • Metabolism of ingested H2SeO4 and H2SeO3 into H2Se
  • Defective PAPSS2 causes SEMD-PA
  • SEMD, Pakistani type
PARD6A par-6 family cell polarity regulator alpha
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Tight junction interactions
  • Asymmetric localization of PCP proteins
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RHOU GTPase cycle
  • RHOV GTPase cycle
PARD6B par-6 family cell polarity regulator beta
  • Tight junction interactions
  • RHOV GTPase cycle
PARP15 poly(ADP-ribose) polymerase family member 15
  • N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE
PARP3 poly(ADP-ribose) polymerase family member 3
  • 2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one
  • 4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one
  • N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE
  • Olaparib
  • Rucaparib
PARVA parvin alpha
  • Localization of the PINCH-ILK-PARVIN complex to focal adhesions
  • Cell-extracellular matrix interactions
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components

Page 64 out of 106 pages